CNB
CRL icon

Czech National Bank’s Charles River Laboratories CRL Stock Holding History

Czech National Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.11M Buy
13,710
+307
+2% +$54.7K 0.02% 473
2026
Q1 		$2.31M Buy
13,403
+426
+3% +$79K 0.02% 480
2025
Q4 		$2.59M Buy
12,977
+477
+4% +$86.5K 0.02% 476
2025
Q3 		$1.96M Buy
12,500
+498
+4% +$79.1K 0.01% 490
2025
Q2 		$1.82M Buy
12,002
+257
+2% +$34.3K 0.01% 488
2025
Q1 		$1.77M Buy
11,745
+657
+6% +$110K 0.02% 489
2024
Q4 		$2.05M Buy
11,088
+571
+5% +$110K 0.02% 470
2024
Q3 		$2.07M Buy
10,517
+701
+7% +$146K 0.02% 466
2024
Q2 		$2.03M Buy
9,816
+791
+9% +$179K 0.02% 455
2024
Q1 		$2.45M Buy
9,025
+41
+0.5% +$9.79K 0.03% 427
2023
Q4 		$2.12M Buy
8,984
+23
+0.3% +$4.52K 0.03% 437
2023
Q3 		$1.76M Buy
8,961
+2,902
+48% +$596K 0.03% 446
2023
Q2 		$1.27M Buy
6,059
+65
+1% +$12.9K 0.03% 447
2023
Q1 		$1.21M Buy
5,994
+39
+0.7% +$8.84K 0.03% 451
2022
Q4 		$1.3M Buy
5,955
+44
+0.7% +$9.61K 0.03% 432
2022
Q3 		$1.16M Buy
+5,911
New +$1.28M 0.03% 435

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Czech National Bank's CRL Position: Q2 2026 in Review

Czech National Bank increased its Charles River Laboratories (CRL) stake by 2.3% in Q2 2026, buying an estimated $54.7K and bringing the position to 13,710 shares worth $3.11M. The position accounts for 0.02% of the portfolio, ranked #473.

Czech National Bank first reported a position in CRL in Q3 2022 and has held it in 16 quarters since. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Czech National Bank held 13,710 shares of Charles River Laboratories worth $3.11M as of Q2 2026.
  • Czech National Bank bought 307 Charles River Laboratories shares in Q2 2026, an estimated $54.7K.
  • Charles River Laboratories made up 0.02% of Czech National Bank's portfolio in Q2 2026, its #473 holding.
  • Czech National Bank first reported a position in Charles River Laboratories in Q3 2022 and has held it in 16 quarters since.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.